Browse Tag


No Omicron immunity without booster, study finds

5 mins read

The FINANCIAL — An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a study by researchers at the Ragon Institute of MGH, MIT and Harvard.…

Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant

4 mins read

The FINANCIAL — Researchers used blood samples collected from Com-COV2 study participants who had received two doses of standard COVID-19 vaccination schedules to perform neutralisation assays using Omicron virus isolate…

FILE PHOTO: People, some wearing protective face masks, walk over Westminster Bridge, amid the coronavirus disease (COVID-19) pandemic, in London, Britain, July 4, 2021. REUTERS/Henry Nicholls/File Photo

Scientists race to define Omicron threat, worried about ‘surge upon a surge’

7 mins read

Harvard experts warn of a “surge upon a surge” in COVID-19 infections in the coming weeks, as cases involving the Omicron variant pile onto the nationwide illness and death the Delta strain has left in its wake in recent months.…

Understanding omicron, the new COVID-19 variant

7 mins read

Countries around the world are making preparations against omicron, a new variant of the novel coronavirus that causes COVID-19. On Wednesday, Dec. 1, omicron’s presence in California was confirmed by the U.S. Centers for Disease Control and Prevention.…

WHO Update on Omicron

7 mins read

The FINANCIAL — On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves,…